The Duke Translational Medicine Institute (DTMI) is Duke’s academic home for the clinical and translational research community. It is an integrated support structure that provides resources and training and facilitates collaborative research in clinical and translational research. The mission of the DTMI is to create a seamless continuum from scientific discovery to care delivery to global health.

The DTMI can assist investigators with all aspects of the research continuum, from preclinical research to clinical trials to community-based research.

Through the DTMI, Duke investigators can:

• Consult with experts in biostatistics and data management
• Obtain assistance with regulatory strategies and submissions
• Access core technology expertise in biobanking and -omics, immune monitoring, cell and tissue therapies, and imaging
• Take advantage of research training and career development opportunities
• Apply for a variety of funding opportunities to support innovative research projects
• Conduct early-phase clinical research projects in dedicated facilities with specialized staff, resources, and expertise

The DTMI serves as the administrative umbrella for a diverse group of Duke entities:

• The Duke Translational Research Institute
• The Duke Clinical Research Institute
  
• The Duke Center for Community Research
• The Duke Clinical Research Unit

Clinical and Translational Science Awards

A national consortium of medical research institutions, funded through Clinical and Translational Science Awards (CTSAs), is working together and shares a common vision to:

• Improve the way biomedical research is conducted across the country
• Reduce the time it takes for laboratory discoveries to become treatments for patients
• Engage communities in clinical research efforts
• Train the next generation of clinical and translational researchers

The CTSA initiative is led by the National Center for Research Resources at the National Institutes of Health.